Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

AstraZeneca

Status: Completed

Conditions: Healthy

Study type: Observational

Funder types: Industry

Identifiers

NCT01211652

NIS-PFR-DUM-2010/1

Details and patient eligibility

About

The purpose of this study is to assess in general population NSAID and gastroprotective agent utilization and compliance in elderly people.

Enrollment: 8,186 patients

Sex: All

Ages: 65+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• French people > 65 years old, part of Kantar Health Access Santé panel

Trial design

8,186 participants in 1 patient group

1